Results 291 to 300 of about 1,827,024 (396)

HEALTHCARE PROFESSIONAL (HCP) PERCEPTIONS OF SICKLE CELL DISEASE (SCD): INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)

Hematology, Transfusion and Cell Therapy, 2020
M.R. Abboud, J. James, N. Ramscar, I. Osunkwo, S.C. Sway   +4 more
doaj  

A Delphi study to identify and prioritize research areas in sickle cell disease in India. [PDF]

Sci Rep
Rulu P, Tabassum H.
europepmc   +1 more source

Extracorporeal Blood Purification Therapy to Deal a Deferasirox Induced Life‐Threatening Hepatic Encephalopathy in a Septic Child With Sickle‐Cell Disease: A Case Report

Journal of Clinical Apheresis, Volume 40, Issue 3, June 2025.
ABSTRACT This report details a rare pediatric case of hyperammonemic encephalopathy caused by the oral iron chelating drug deferasirox (DFR) in a septic patient. It is our contention that this study lends support to the existing literature, as it describes the case of a 15‐year‐old female patient with a history of sickle‐cell disease who presented with
E. Rossetti, A. Cappoli, R. Labbadia, G. Leone, F. Chiusolo, F. Tortora, D. Martinelli, M. Marano   +7 more
wiley   +1 more source

Altered nasal and oral microbiomes define pediatric sickle cell disease. [PDF]

mSphere
Crouch AL, Severance BM, Creary S, Hood D, Bailey M, Mejias A, Ramilo O, Gillespie M, Ebelt S, Sheehan V, Kopp BT, Anderson MZ.   +11 more
europepmc   +1 more source

Decreased serum tuftsin concentrations in sickle cell disease.

, 1980
Z Spirer, Y. Weisman, Vera Zakuth, Mati Fridkin, N Bogair   +4 more
openalex   +1 more source

Impact of Voxelotor on Red Blood Cell Exchange Therapeutic Procedures: Evaluation of Multi‐Institutional Procedure Data

Journal of Clinical Apheresis, Volume 40, Issue 3, June 2025.
ABSTRACT Hemoglobin S (HbS) polymerization inhibitor drugs such as voxelotor can result in a split peak in HbS as well as additional peaks with hemoglobin A in quantitative methods of HbS measurement. It is unclear how these results should be used to make transfusion decisions.
Sally Campbell‐Lee, Ming Jin, Lisandro Fortuny, Daniel Sop, Suzanne Thibodeaux, Susan D‐Roseff   +5 more
wiley   +1 more source

Liver Transplant for Acute Cholestatic Crisis in Sickle Cell Disease. [PDF]

Transpl Int
Welland S, Kamp JC, Hartleben B, Taubert R, Abu Isneineh R.   +4 more
europepmc   +1 more source

Adolescents' and young adults' reactions to and perceived utility of carrier screening results in the context of a genomic research study

Journal of Genetic Counseling, Volume 34, Issue 3, June 2025.
Abstract Although guidelines have historically recommended deferring decisions about learning genomic information for conditions not actionable in childhood until adulthood, youth have increasing access to personal genomic information through research, clinical, and direct‐to‐consumer testing. However, little is known about young people's reactions to,
Haley N. Grimes, Michelle L. McGowan, Jessica A. Sinclair, Cynthia A. Prows, Ellen A. Lipstein, Melanie F. Myers   +5 more
wiley   +1 more source

USE OF OPIOIDS AND BURDEN OF DISEASE IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) IN BRAZIL VS THE OVERALL POPULATION OF THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)

Hematology, Transfusion and Cell Therapy, 2020
M. Pita, J. James, S. Forny, N. Ramscar, I. Osunkwo   +4 more
doaj  

Real-World Experience of L-Glutamine in Sickle Cell Disease: A Retrospective Observational Study. [PDF]

Pharmacy (Basel)
Turkistani S, AlHarbi A, Khan M, AlAzmi A, Almutairi S, Elimam N, Alotaibi S.   +6 more
europepmc   +1 more source